|
1
|
Pedersen SW, Suedmeyer M, Liu LW, Domagk
D, Forbes A, Bergmann L, Onuk K, Yegin A and van Laar T: The role
and structure of the multidisciplinary team in the management of
advanced Parkinson's disease with a focus on the use of
levodopa-carbidopa intestinal gel. J Multidiscip Healthc. 10:13–27.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Grimes D, Fitzpatrick M, Gordon J,
Miyasaki J, Fon EA, Schlossmacher M, Suchowersky O, Rajput A,
Lafontaine AL, Mestre T, et al: Canadian guideline for Parkinson
disease. CMAJ. 191:E989–E1004. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Amjad F, Bhatti D, Davis TL, Oguh O, Pahwa
R, Kukreja P, Zamudio J and Metman LV: Current practices for
outpatient initiation of levodopa-carbidopa intestinal gel for
management of advanced Parkinson's disease in the United States.
Adv Ther. 36:2233–2246. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tran BX, Vu GT, Ha GH, Vuong QH, Ho MT,
Vuong TT, La VP, Ho MT, Nghiem KP, Nguyen HLT, et al: Global
evolution of research in artificial intelligence in health and
medicine: A bibliometric study. J Clin Med. 8(360)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yang W, Hamilton JL, Kopil C, Beck JC,
Tanner CM, Albin RL, Ray Dorsey E, Dahodwala N, Cintina I, Hogan P
and Thompson T: Current and projected future economic burden of
Parkinson's disease in the U.S. NPJ Parkinsons Dis.
6(15)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li MH, Mestre TA, Fox SH and Taati B:
Vision-based assessment of parkinsonism and levodopa-induced
dyskinesia with pose estimation. J Neuroeng Rehabil.
15(97)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shamir RR, Dolber T, Noecker AM, Walter BL
and McIntyre CC: Machine learning approach to optimizing combined
stimulation and medication therapies for Parkinson's disease. Brain
Stimul. 8:1025–1032. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tucker CS, Behoora I, Nembhard HB, Lewis
M, Sterling NW and Huang X: Machine learning classification of
medication adherence in patients with movement disorders using
non-wearable sensors. Comput Biol Med. 66:120–134. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Turner AP, Lones MA, Trefzer MA, Smith SL,
Jamieson S, Alty JE, Cosgrove J and Tyrrell AM: Using epigenetic
networks for the analysis of movement associated with levodopa
therapy for Parkinson's disease. Biosystems. 146:35–42.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yue Z, Arora I, Zhang EY, Laufer V,
Bridges SL and Chen JY: Repositioning drugs by targeting network
modules: A Parkinson's disease case study. BMC Bioinformatics. 18
(Suppl 14)(S532)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Przybyszewski AW, Kon M, Szlufik S,
Szymanski A, Habela P and Koziorowski DM: Multimodal learning and
intelligent prediction of symptom development in individual
Parkinson's patients. Sensors (Basel). 16(1498)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Willows T, Dizdar N, Nyholm D, Widner H,
Grenholm P, Schmiauke U, Urbom A, Groth K, Larsson J, Permert J and
Kjellander S: Initiation of levodopa-carbidopa intestinal gel
infusion using telemedicine (video communication system)
facilitates efficient and well-accepted home titration in patients
with advanced Parkinson's disease. J Parkinsons Dis. 7:719–728.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Evans L, Mohamed B and Thomas EC: Using
telemedicine and wearable technology to establish a virtual clinic
for people with Parkinson's disease. BMJ Open Qual.
9(e001000)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hssayeni MD, Jimenez-Shahed J, Burack MA
and Ghoraani B: Wearable sensors for estimation of parkinsonian
tremor severity during free body movements. Sensors (Basel).
19(4215)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cilia R, Mancini F, Bloem BR and Eleopra
R: Telemedicine for parkinsonism: A two-step model based on the
COVID-19 experience in Milan, Italy. Parkinsonism Relat Disord.
75:130–132. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Beck CA, Beran DB, Biglan KM, Boyd CM,
Dorsey ER, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz
M, et al: National randomized controlled trial of virtual house
calls for Parkinson disease. Neurology. 89:1152–1161.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lo AC, Chang VC, Gianfrancesco MA,
Friedman JH, Patterson TS and Benedicto DF: Reduction of freezing
of gait in Parkinson's disease by repetitive robot-assisted
treadmill training: A pilot study. J Neuroeng Rehabil.
7(51)2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nardo A, Anasetti F, Servello D and Porta
M: Quantitative gait analysis in patients with Parkinson treated
with deep brain stimulation: The effects of a robotic gait
training. NeuroRehabilitation. 35:779–788. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Picelli A, Melotti C, Origano F, Waldner
A, Fiaschi A, Santilli V and Smania N: Robot-assisted gait training
in patients with Parkinson disease: A randomized controlled trial.
Neurorehabil Neural Repair. 26:353–361. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Galli M, Cimolin V, De Pandis MF, Le Pera
D, Sova I, Albertini G, Stocchi F and Franceschini M:
Robot-assisted gait training versus treadmill training in patients
with Parkinson's disease: A kinematic evaluation with gait profile
score. Funct Neurol. 31:163–170. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kang MG, Yun SJ, Shin HI, Kim E, Lee HH,
Oh BM and Seo HG: Effects of robot-assisted gait training in
patients with Parkinson's disease: Study protocol for a randomized
controlled trial. Trials. 20(15)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fundarò C, Maestri R, Ferriero G, Chimento
P, Taveggia G and Casale R: Self-selected speed gait training in
Parkinson's disease: Robot-assisted gait training with virtual
reality versus gait training on the ground. Eur J Phys Rehabil Med.
55:456–462. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Capecci M, Pournajaf S, Galafate D, Sale
P, Le Pera D, Goffredo M, De Pandis MF, Andrenelli E, Pennacchioni
M, Ceravolo MG and Franceschini M: Clinical effects of
robot-assisted gait training and treadmill training for Parkinson's
disease. A randomized controlled trial. Ann Phys Rehabil Med.
62:303–312. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Arami A, Poulakakis-Daktylidis A, Tai YF
and Burdet E: Prediction of gait freezing in parkinsonian patients:
A binary classification augmented with time series prediction. IEEE
Trans Neural Syst Rehabil Eng. 27:1909–1919. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shalin G, Pardoel S, Nantel J, Lemaire ED
and Kofman J: Prediction of freezing of gait in Parkinson's disease
from foot plantar-pressure arrays using a convolutional neural
network. Annu Int Conf IEEE Eng Med Biol Soc. 2020:244–247.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bevilacqua R, Maranesi E, Di Rosa M, Luzi
R, Casoni E, Rinaldi N, Baldoni R, Lattanzio F, Di Donna V,
Pelliccioni G and Riccardi GR: Rehabilitation of older people with
Parkinson's disease: An innovative protocol for RCT study to
evaluate the potential of robotic-based technologies. BMC Neurol.
20(186)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dorsey ER, Elbaz A, Nichols E, Abd-Allah
F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C, Choi JYJ,
Collado-Mateo D, et al: Global, regional, and national burden of
Parkinson's disease,1990-2016: A systematic analysis for the Global
Burden of Disease Study 2016. Lancet Neurol. 17:939–953.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
De Raeve P, Adams E and Xyrichis A: The
impact of the COVID-19 pandemic on nurses in Europe: A critical
discussion of policy failures and opportunities for future
preparedness. Int J Nurs Stud Adv. 3(100032)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cesario A, D'Oria M, Calvani R, Picca A,
Pietragalla A, Lorusso D, Daniele G, Lohmeyer FM, Boldrini L,
Valentini V, et al: The role of artificial intelligence in managing
multimorbidity and cancer. J Pers Med. 11(314)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Prakash N and Simuni T: Infusion therapies
for Parkinson's disease. Curr Neurol Neurosci Rep.
20(44)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Keränen T, Kaakkola S, Sotaniemi K,
Laulumaa V, Haapaniemi T, Jolma T, Kola H, Ylikoski A, Satomaa O,
Kovanen J, et al: Economic burden and quality of life impairment
increase with severity of PD. Parkinsonism Relat Disord. 9:163–168.
2003.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Grandas F, Galiano ML and Tabernero C:
Risk factors for levodopa-induced dyskinesias in Parkinson's
disease. J Neurol. 246:1127–1133. 1999.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Fabbrini G, Brotchie JM, Grandas F, Nomoto
M and Goetz CG: Levodopa-induced dyskinesias. Mov Disord.
22:1379–1389. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Nutt JG: Motor fluctuations and dyskinesia
in Parkinson's disease. Parkinsonism Relat Disord. 8:101–108.
2001.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Olanow CW: Levodopa: Effect on cell death
and the natural history of Parkinson's disease. Mov Disord.
30:37–44. 2015.PubMed/NCBI View Article : Google Scholar
|
